At a glance
- Originator Pfizer
- Class Antimigraines; Anxiolytics
- Mechanism of Action Serotonin 1B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 23 Jun 2000 No-Development-Reported for Migraine (Unknown route)
- 22 Dec 1998 Preclinical development for Migraine (Unknown route)